Skip to NavigationSkip to content

Context Therapeutics add new CMO

Published on: 24/07/17

Context Therapeutics, a biotech company that focuses on the development of treatments for Sigma1-related diseases, has announced that a new Chief Medical Officer has joined its team. Erad Gilles, most recently of Invivis Pharmaceuticals, will take up the position permanently after previously having operated as Consulting CMO for the company.

Gilles role prior to joining Context was as founder of Invivis, as well as performing the role of Chief Medical Officer – a company that developed an anti-progestin therapy and biomarker that was licensed by Arno Therapeutics.

Beyond this, he has a varied working history as a Director of Oncology at Roche for three years, spending six years as Vice President of Oncology at Pfizer before moving onto roles at Sanofi and J&J.

“Context is a great innovator in Sigma1 biology and therapeutics, and the Company is emblematic of the science-driven, precision medicine approach that will bring about much-needed therapies for cancer patients,” said Dr Gilles on his appointment. “I am delighted to have the opportunity to lead Context’s clinical programs at such a pivotal time for the Company.”

“We are excited to welcome Erard to Context as chief medical officer,” said Martin Lehr, Chief Executive Officer. “His extraordinary medical and scientific expertise and strong relationships in the oncology community, both within the US and Europe, will be invaluable as Context pursues its mission to change the world for patients with advanced cancer through bold and innovative science.”

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches